D-0878-2023 Class II Terminated
FDA drug recall D-0878-2023 was initiated by The Harvard Drug Group on Jun 16, 2023 and is designated Class II. Reason for recall: Packaging defect: blister packaging inadequately sealed. The recall status is terminated (terminated Apr 30, 2024). Affected quantity: 3876 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 5, 2023
- Initiation Date
- Jun 16, 2023
- Termination Date
- Apr 30, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3876 cartons
Product description
Tramadol Hydrochloride Tablets, USP 50 mg, Unit Dose 100-Count Tablets Rx only, Manufactured by: Sun Pharmaceutical Industries Ltd. Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), India. Distributed by: Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Distributed by: Major Pharmaceuticals Livonia, MI 48152 USA, NDC 0904-7179-61
Reason for recall
Packaging defect: blister packaging inadequately sealed.
Distribution pattern
Nationwide in the U.S.
Code information
Lot #: M04343, Exp. 04/2024
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0878-2023
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026